These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Synthesis and pharmacological evaluation of novel substituted 9-deazaxanthines as A2B receptor antagonists. Nieto MI; Balo MC; Brea J; Caamaño O; Fernández F; García-Mera X; López C; Loza MI; Rodríguez-Borges JE; Vidal B Eur J Med Chem; 2010 Jul; 45(7):2884-92. PubMed ID: 20371139 [TBL] [Abstract][Full Text] [Related]
9. 1-alkyl-8-(piperazine-1-sulfonyl)phenylxanthines: development and characterization of adenosine A2B receptor antagonists and a new radioligand with subnanomolar affinity and subtype specificity. Borrmann T; Hinz S; Bertarelli DC; Li W; Florin NC; Scheiff AB; Müller CE J Med Chem; 2009 Jul; 52(13):3994-4006. PubMed ID: 19569717 [TBL] [Abstract][Full Text] [Related]
10. Development of spin-labeled probes for adenosine receptors. Ilas J; Pecar S; Hockemeyer J; Euler H; Kirfel A; Müller CE J Med Chem; 2005 Mar; 48(6):2108-14. PubMed ID: 15771453 [TBL] [Abstract][Full Text] [Related]
12. The discovery of a selective, high affinity A(2B) adenosine receptor antagonist for the potential treatment of asthma. Zablocki J; Kalla R; Perry T; Palle V; Varkhedkar V; Xiao D; Piscopio A; Maa T; Gimbel A; Hao J; Chu N; Leung K; Zeng D Bioorg Med Chem Lett; 2005 Feb; 15(3):609-12. PubMed ID: 15664822 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and structure-activity relationships of 1-,3-,8-, and 9-substituted-9-deazaxanthines at the human A2B adenosine receptor. Carotti A; Cadavid MI; Centeno NB; Esteve C; Loza MI; Martinez A; Nieto R; Raviña E; Sanz F; Segarra V; Sotelo E; Stefanachi A; Vidal B J Med Chem; 2006 Jan; 49(1):282-99. PubMed ID: 16392813 [TBL] [Abstract][Full Text] [Related]
14. [3H]-MRE 2029-F20, a selective antagonist radioligand for the human A2B adenosine receptors. Baraldi PG; Tabrizi MA; Preti D; Bovero A; Fruttarolo F; Romagnoli R; Moorman AR; Gessi S; Merighi S; Varani K; Borea PA Bioorg Med Chem Lett; 2004 Jul; 14(13):3607-10. PubMed ID: 15177484 [TBL] [Abstract][Full Text] [Related]
15. Discovery of a novel A2B adenosine receptor antagonist as a clinical candidate for chronic inflammatory airway diseases. Elzein E; Kalla RV; Li X; Perry T; Gimbel A; Zeng D; Lustig D; Leung K; Zablocki J J Med Chem; 2008 Apr; 51(7):2267-78. PubMed ID: 18321039 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and pharmacological evaluation of novel 1,3,8- and 1,3,7,8-substituted xanthines as adenosine receptor antagonists. Rodríguez-Borges JE; García-Mera X; Balo MC; Brea J; Caamaño O; Fernández F; López C; Loza MI; Nieto MI Bioorg Med Chem; 2010 Mar; 18(5):2001-9. PubMed ID: 20137957 [TBL] [Abstract][Full Text] [Related]
17. A new synthesis of sulfonamides by aminolysis of p-nitrophenylsulfonates yielding potent and selective adenosine A2B receptor antagonists. Yan L; Bertarelli DC; Hayallah AM; Meyer H; Klotz KN; Müller CE J Med Chem; 2006 Jul; 49(14):4384-91. PubMed ID: 16821798 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and pharmacological evaluation of novel 1- and 8-substituted-3-furfuryl xanthines as adenosine receptor antagonists. Balo MC; Brea J; Caamaño O; Fernández F; García-Mera X; López C; Loza MI; Nieto MI; Rodríguez-Borges JE Bioorg Med Chem; 2009 Sep; 17(18):6755-60. PubMed ID: 19682912 [TBL] [Abstract][Full Text] [Related]